Changes in body weight during pharmacological treatment of depression

International Journal of Neuropsychopharmacology

Volumn 14, Issue 3, 2011, Pages 367-375

  Uher, Rudolf ^a   Mors, Ole ^b   Hauser, Joanna ^c   Rietschel, Marcella ^d   Maier, Wolfgang ^e   Kozel, Dejan ^f   Henigsberg, Neven ^g   Souery, Daniel ^h   Placentino, Anna ⁱ   Keers, Robert ^a   Gray, Joanna M ^a   Dernovsek, Mojca Zvezdana ^j   Strohmaier, Jana ^d   Larsen, Erik Roj ^b   Zobel, Astrid ^e   Szczepankiewicz, Aleksandra ^c   Kalember, Petra ^g   Mendlewicz, Julien ^h   Aitchison, Katherine J ^a   McGuffin, Peter ^a   Farmer, Anne ^a   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h ERASME HOSPITAL   (Belgium)

ⁱ SPEDALI CIVILI   (Italy)

^j Educational and Research Institute Ozara   (Slovenia)

more..

Author keywords

adverse effects; Antidepressants; body weight; major depressive disorder

Indexed keywords

ESCITALOPRAM; NORTRIPTYLINE;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BODY MASS INDEX; BODY WEIGHT; CITALOPRAM; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE; OBESITY; SEROTONIN UPTAKE INHIBITORS; WEIGHT GAIN; WEIGHT LOSS; YOUNG ADULT;

EID: 79960382493     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000933     Document Type: Article

References (36)

1. Álvarez-Jiménez M, Hetrick SE, Gonzalez-Blanch C, Gleeson JF, et al. (2008). Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. British Journal of Psychiatry 193, 101-107
2. Baptista T, ElFakih Y, Uzcategui E, Sandia I, et al. (2008). Pharmacological management of atypical antipsychoticinduced weight gain. CNS Drugs 22, 477-495 (Pubitemid 351693690)
3. Benazzi F (1998). Weight gain in depression remitted with antidepressants: pharmacological or recovery effect? Psychotherapy Psychosomatics 67, 271-274 (Pubitemid 28386473)
4. Berken GH, Weinstein DO, Stern WC (1984). Weight gain. A side-effect of tricyclic antidepressants. Journal of Affective Disorders 7, 133-138 (Pubitemid 14028739)
5. Cassano P, Fava M (2004). Tolerability issues during long-term treatment with antidepressants. Annals of Clinical Psychiatry 16, 15-25 (Pubitemid 40029200)
6. Demyttenaere K, Albert A, Mesters P, Dewe W, et al. (2005). What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors? Journal of Clinical Psychiatry 66, 859-863 (Pubitemid 41032827)
7. Fava M (2000). Weight gain and antidepressants. Journal of Clinical Psychiatry 61 (Suppl. 11), 37-41 (Pubitemid 30616693)
8. Fava M, Judge R, Hoog SL, Nilsson ME, et al. (2000). Fluoxetine vs. sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. Journal of Clinical Psychiatry 61, 863-867
9. Fernstrom MH, Kupfer DJ (1988). Antidepressant-induced weight gain: a comparison study of four medications. Psychiatry Research 26, 265-271 (Pubitemid 19021045)
10. Goethe JW, Woolley SB, Cardoni AA, Woznicki BA, et al. (2007). Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence. Journal of Clinical Psychopharmacology 27, 451-458 (Pubitemid 47415042)
11. Gueorguieva R, Krystal JH (2004). Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Archives of General Psychiatry 61, 310-317 (Pubitemid 38295833)
12. Haney EM, Warden SJ (2008). Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies. Journal of Musculoskeletal and Neuronal Interactions 8, 133-145
13. Keers R, Bonvicini C, Scassellati C, Uher R, et al. (in press). Variation in GNB3 predicts response and adverse reactions to antidepressants. Journal of Psychopharmacology
14. Khan A, Schwartz KA, Kolts RL, Brown WA (2007). BMI, sex, and antidepressant response. Journal of Affective Disorders 99, 101-106 (Pubitemid 46275023)
15. Kloiber S, Ising M, Reppermund S, Horstmann S, et al. (2007). Overweight and obesity affect treatment response in major depression. Biological Psychiatry 62, 321-326 (Pubitemid 47444280)
16. Lane P (2008). Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharmaceutical Statistics 7, 93-106 (Pubitemid 351943638)
17. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, et al. (1987). The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica 334 (Suppl.), 1-100 (Pubitemid 17115352)
18. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, et al. (2010). Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry 67, 220-229
19. Michelson D, Amsterdam JD, Quitkin FM, Reimherr FW, et al. (1999). Changes in weight during a 1-year trial of fluoxetine. American Journal of Psychiatry 156, 1170-1176 (Pubitemid 29374875)
20. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389 (Pubitemid 9136500)
21. Nierenberg AA, Husain MM, Trivedi MH, Fava M, et al. (2010). Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychological Medicine 40, 41-50
22. Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, et al. (2003). Nortriptyline for treatment-resistant depression. Journal of Clinical Psychiatry 64, 35-39 (Pubitemid 36182227)
23. NIH (1998). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National Institutes of Health. Obesity Research 6 (Suppl. 2), 51S-209S.
24. Oskooilar N, Wilcox CS, Tong ML, Grosz DE (2009). Body mass index and response to antidepressants in depressed research subjects. Journal of Clinical Psychiatry 70, 1609-1610
25. Papakostas GI, Petersen T, Iosifescu DV, Burns AM, et al. (2005). Obesity among outpatients with major depressive disorder. International Journal of Neuropsychopharmacology 8, 59-63 (Pubitemid 40388814)
26. Paradis CF, Stack JA, George CJ, Miller MD, et al. (1992). Nortriptyline and weight change in depressed patients over 60. Journal of Clinical Psychopharmacology 12, 246-250
27. Patten SB, Williams JV, Lavorato DH, Brown L, et al. (2009). Major depression, antidepressant medication and the risk of obesity. Psychotherapy Psychosomatics 78, 182-186
28. Paykel ES, Mueller PS, De l V (1973). Amitriptyline, weight gain and carbohydrate craving: a side effect. British Journal of Psychiatry 123, 501-507
29. Secher A, Bukh J, Bock C, Koefoed P, et al. (2009). Antidepressive-drug- induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1. International Clinical Psychopharmacology 24, 199-203
30. StataCorp (2007). Stata Statistical Software: Release 10 Stata Corp LP: College Station, TX
31. Uher R, Farmer A, Henigsberg N, Rietschel M, et al. (2009a). Adverse reactions to antidepressants. British Journal of Psychiatry 195, 202-210
32. Uher R, Farmer A, Maier W, Rietschel M, et al. (2008). Measuring depression: comparison and integration of three scales in the GENDEP study. Psychological Medicine 38, 289-300 (Pubitemid 351156595)
33. Uher R, Maier W, Hauser J, Marusic A, et al. (2009b). Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. British Journal of Psychiatry 194, 252-259
34. Uher R, Mors O, Hauser J, Rietschel M, et al. (2009c). Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders 118, 147-154
35. WHO (1998). Obesity: preventing and managing the global epidemic. In Report of a World Health Organisation Consultation on Obesity, Geneva, 3-5 June 1997. World Health Organisation: Geneva
36. Wing JK, Sartorius N, Ustin TB (1998). Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN. World Health Organization: Geneva